Jun 04, 2020
Duchesnay USA and FabOverFifty launch Straight Talk: Sex and the Menopausal Woman video
Jun 03, 2020
American Regent Introduces Estradiol Valerate Injection, USP­; AO Rated and Therapeutically Equivalent to Delestrogen®1, 2
May 19, 2020
Duchesnay USA and Plushcare announce a new partnership to facilitate access to healthcare for menopausal women through telemedicine
Mar 23, 2020
Global Vasomotor Symptoms Market (2017 to 2030) - Featuring TherapeuticsMD, Astellas Pharma & Mitsubishi Tanabe Pharma Among Others
Mar 16, 2020
Vasomotor Symptoms Market Size is Growing at a CAGR of 7% | Some of the Major Players are KaNDy Therapeutics, Fervent Pharmaceuticals, Astellas Pharma, Sojournix, Mitsubishi Tanabe Pharma
Feb 10, 2020
US Breast Cancer Drug Market, Price, Dosage & Clinical Pipeline Insight 2025
Dec 17, 2019
Gennev Reveals Menopause Zeitgeist: Social Taboos, Symptoms, and Surprising Gaps in Support
Nov 06, 2019
Endoceutics® Receives Health Canada Approval for INTRAROSA®
Aug 13, 2019
Duchesnay USA announces the launch of a new Osphena® (ospemifene) website
Aug 06, 2019
Astellas Initiates Phase 3 Clinical Trials for Fezolinetant in Postmenopausal Women with Vasomotor Symptoms
Jul 10, 2019
Women's Excellence Now Offers Comprehensive Menopause Care
Jul 08, 2019
National Survey Launched to Identify Key Health Concerns Facing Menopausal Women
Jun 25, 2019
Hormone Replacement Therapy (HRT): Global Market Strategy Report 2016-2024 - Transdermal HRT Products Present Exciting Opportunities
Apr 11, 2019
Introducing EQUELLE®: A New Non-Hormonal Supplement for Menopause Symptom Relief**
Mar 23, 2019
Sojournix Poster Presentation At ENDO 2019 Features Positive Data From SJX-653 Proof-of-Mechanism Clinical Study
Feb 14, 2019
diVa By Sciton Receives Approved Indication For The Treatment Of Genitourinary Symptoms Of Menopause (GSM) By Health Canada
Feb 13, 2019
Sojournix Announces Positive Top-Line Phase 1 Data Demonstrating Clinical Proof of Mechanism and Once-Daily (QD) Pharmacokinetics for SJX-653
Feb 04, 2019
Sojournix Appoints Ruth Thieroff-Ekerdt, M.D. As Senior Vice President And Chief Medical Officer
Jan 29, 2019
Duchesnay Inc. Receives Approval of Supplemental New Drug Application (sNDA) to Add Moderate to Severe Vaginal Dryness, a Symptom of Vulvar and Vaginal Atrophy (VVA) Due to Menopause, to the Indication of Osphena® (ospemifene)
Jan 24, 2019
Amerigen Announces U.S. FDA Approval For Generic Mixed Amphetamine Salts, Extended-Release Capsules